Cargando…
Progressive Multifocal Leukoencephalopathy: Current Insights
Cases of PML should be evaluated according to predisposing factors, as these subgroups differ by incidence rate, clinical course, and prognosis. The three most significant groups at risk of PML are patients with hematological malignancies mostly previously treated with immunotherapies but also untre...
Autores principales: | Kartau, Marge, Sipilä, Jussi OT, Auvinen, Eeva, Palomäki, Maarit, Verkkoniemi-Ahola, Auli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896915/ https://www.ncbi.nlm.nih.gov/pubmed/31819703 http://dx.doi.org/10.2147/DNND.S203405 |
Ejemplares similares
-
The Incidence and Predisposing Factors of John Cunningham Virus-Induced Progressive Multifocal Leukoencephalopathy in Southern Finland: A Population-Based Study
por: Kartau, Marge, et al.
Publicado: (2019) -
Progressive multifocal leukoencephalopathy in Finland: a cross-sectional registry study
por: Sipilä, Jussi O. T., et al.
Publicado: (2019) -
JC Polyomavirus Modifies the Expression of Human microRNAs in Progressive Multifocal Leukoencephalopathy Brain
por: Honkimaa, Anni, et al.
Publicado: (2023) -
Progressive Multifocal Leukoencephalopathy
por: Adang, Laura, et al.
Publicado: (2015) -
Safety of alemtuzumab in a nationwide cohort of Finnish multiple sclerosis patients
por: Rauma, Ilkka, et al.
Publicado: (2021)